Safety study of endoscopic intragastric balloon placement for obese patients with endocrine and metabolic diseases

Safety study of endoscopic intragastric balloon placement for obese patients with endocrine and metabolic diseases - Safety study of endoscopic intragastric balloon placement for obese patients with endocrine and metabolic diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040991

Enrollment

Registered

2020-07-02

Start date

2019-11-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obese patients with any of the metabolic disorders (diabetes, hypertension, dyslipidemia are diagnosed according to the diagnostic criteria of the Japan Diabetes Society, The Japanese Society of Internal Medicine, Japanese Atherosclerotic Disease Prevention Guidelines)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: N/A

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
Safety of endoscopic intragastric balloon placement	—

Countries

Japan

Contacts

Public ContactTomoyuki Hayashi

Kanazawa university Gastroenterology

tohayashi@m-kanazawa.jp076-265-2235

Outcome results